泰华堂品牌怎么样 申请店铺

我要投票 泰华堂在医疗保健行业中的票数:328 更新时间:2025-07-24
泰华堂是哪个国家的品牌?「泰华堂」是 四川泰华堂制药有限公司 旗下著名品牌。该品牌发源于四川省成都市,由创始人张兵在2001-02-26期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力泰华堂品牌出海!将品牌入驻外推网,定制泰华堂品牌推广信息,可以显著提高泰华堂产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

泰华堂怎么样

始建于1988年,核与辐射防护药物研究和产业基地,国家核工业系统下属军民结合大型综合型制药企业

四川泰华堂制药有限公司始建于1988年,是国家核工业系统下属军民结合大型综合型制药企业。公司现已发展为资产过亿元、占地400余亩、职工1000余人,拥有胶囊剂、片剂、口服液等9条国家GMP达标生产线,产品达100多个。

将该技术在中药复方提取分离纯化中成功运用并实现产业化生产。通过三位一体的大孔树脂吸附,精提复方中药的全部有效成分,使其剂量较小,服用量更少更方便。去粗取精,中药西制,提升了传统中药的内在品质,使之达到国际绿色标准,被国内药学专家堪称中药现代化之典范。

目前该技术已成功应用到精品六味地黄胶囊,藿香正气胶囊以及补肾精品补肾益气胶囊,因其服用量少,生物利用度高,临床疗效显著,副作用小等独特优势,深受广大患者青睐和好评。

二十多年来,泰华堂始终秉承军工本色,精益求精,产品质量过硬,内在品质好疗效显著等口碑赢得业界和广大消费者的赞誉和青睐,让药品真正回归到治病救人预防养生的本质,这也是泰华堂立命之基础,持续发展之根本。

公司为民众健康保驾护航,正推进四川泰华堂连锁公司和四川泰华堂绿色科技公司筹建,加强四川泰华堂医贸公司、四川泰华堂健康科技公司两家全资子公司的运营管理,实现医药产业全链发展战略。极力打造集医药研发、医药工业制造、医药贸易、大健康产品研发制造等几大产业体系于一体的大型综合产业集团。


Founded in 1988, it is a research and industrial base of nuclear and radiation protection drugs. Sichuan taihuatang Pharmaceutical Co., Ltd., a large-scale integrated military civilian pharmaceutical enterprise under the national nuclear industry system, was founded in 1988. It is a large-scale integrated military civilian pharmaceutical enterprise under the national nuclear industry system. The company has developed into a company with assets of over 100 million yuan, covering an area of more than 400 mu and more than 1000 employees. It has 9 National GMP production lines, including capsule, tablet and oral liquid, with more than 100 products. The technology has been successfully applied in the extraction, separation and purification of traditional Chinese medicine and industrialized production has been realized. Through the adsorption of the big porous resin, all the effective components of the compound Chinese medicine are refined, so that the dosage is smaller and the dosage is less and more convenient. Traditional Chinese medicine is made in the west, which improves the internal quality of traditional Chinese medicine and makes it reach the international green standard. It is regarded as a model of modernization of traditional Chinese medicine by domestic pharmaceutical experts. At present, the technology has been successfully applied to the boutique Liuwei Dihuang capsule, Huoxiang Zhengqi Capsule and Bushen boutique Bushen Yiqi capsule. Because of its unique advantages, such as small dosage, high bioavailability, significant clinical effect and small side effects, it is favored and praised by the majority of patients. Over the past 20 years, taihutang has always been adhering to the nature of military industry, striving for excellence, excellent product quality, good internal quality and remarkable curative effect, and won the praise and favor of the industry and consumers, so as to make drugs truly return to the essence of curing diseases, saving people, prevention and health preservation, which is also the foundation of taihutang's life and the foundation of sustainable development. The company is protecting people's health, promoting the preparation of Sichuan taihutang chain company and Sichuan taihutang green technology company, strengthening the operation management of two wholly-owned subsidiaries of Sichuan taihutang medical trade company and Sichuan taihutang health technology company, and realizing the whole chain development strategy of the pharmaceutical industry. Strive to build a large-scale comprehensive industrial group integrating pharmaceutical R & D, pharmaceutical industry manufacturing, pharmaceutical trade, R & D and manufacturing of large health products and other industrial systems.

本文链接: https://brand.waitui.com/61a5d83c9.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

商汤:拟折价6.25%配售新股筹资25亿港元

36氪获悉,商汤在港交所公告,2025年7月23日,公司订立与认购人之间的认购协议,据此,认购人已有条件同意认购,且公司有条件同意配发及发行合共约16.66亿股认购股份,每股认购股份的认购价为1.50港元,总代价约为25亿港元。认购价较最新收盘价折价约6.25%。

2小时前

二季度公募基金增持银行股,持仓总市值环比增长约27%

今年二季度,公募基金对银行股整体呈现增持趋势。Wind资讯数据显示,截至今年二季度末,公募基金对银行股的持仓总市值达2053.69亿元,较今年一季度的1616.07亿元环比上涨约27%。在业内人士看来,政策效应显现推动各类资产价格企稳回升、公募基金对低配板块的关注度提升以及红利策略逻辑的演绎等多方面因素,共同推动了二季度公募基金对银行股的增持。站在当前时点,尽管银行板块有所调整,但中期行情或尚未结束,投资吸引力仍存。(证券日报)

2小时前

我科学家实现高效体细胞克隆

7月23日,从中国科学院遗传与发育生物学研究所获悉,来自该所、中国科学院脑科学与智能技术卓越创新中心的科研人员,开发出一套高效组合技术策略,首次同时克服了体细胞克隆胚胎发育过程中面临的两大表观遗传障碍,创下了当前小鼠体细胞克隆效率的世界最高纪录,为哺乳动物高效体细胞克隆提供了一种切实可行的技术策略。相关研究成果发表于《先进科学》杂志。(科技日报)

2小时前

白宫发布人工智能政策愿景,确保美国科技主导地位

特朗普政府发布新指南,要求放松监管、对数据中心扩大能源供应,以促进美国人工智能(AI)发展,同时还敦促停止资助那些对新兴技术实施过多监管的州。这份白宫周三发布的AI行动计划建议改革许可流程,简化环境标准,以加快AI相关的基础设施项目推进。这项蓝图还力求让美国技术成为全球AI的基础,同时制定安全措施。“实现并保持无可争议、不可挑战的全球技术主导地位是美国国家安全的当务之急,”美国总统唐纳德·特朗普在这份报告中表示,“为了保障我们的未来,我们必须全力利用美国创新的力量。”(新浪财经)

2小时前

华泰证券:“反内卷”政策预期或催化煤炭板块估值修复

36氪获悉,华泰证券研报表示,煤炭旺季已至,需求回暖催化煤价修复;供需宽松下生产端或有以量补价,“反内卷”政策预期推升市场情绪,有望催化煤炭板块估值修复。重申煤炭板块的红利逻辑,建议关注盈利能力稳健有望保持高分红比例的动力煤龙头,以及去年以来超产现象大幅减少的山西地区相关龙头公司。

2小时前

本页详细列出关于泰华堂的品牌信息,含品牌所属公司介绍,泰华堂所处行业的品牌地位及优势。
咨询